Department of Materials Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran.
Biomater Adv. 2022 Mar;134:112541. doi: 10.1016/j.msec.2021.112541. Epub 2021 Nov 17.
Recently, nanofibrous structures have shown great potential for a wide range of medical applications. The aim of the current study was to evaluate the wound healing process using Polycaprolactone/Keratin/Platelet-rich fibrin (PCL/Kr/PRF) fibrous scaffold fabricated through electrospinning process. A range of techniques were utilized to fully characterize the chemical, physical and biological properties of the resultant structure. Results revealed that by the addition of only 0.5%w/v PRF to PCL/Kr (PCL/Kr/0.5PRF) sample, the fibers diameter decreased from 193.93 ± 64.80 nm to 65.98 ± 14.03 nm, and the stress at break demonstrated a 18.27% increase in comparison to the PCL sample (from 2.90 ± 0.80 MPa to 3.43 ± 0.90 MPa). The PCL/Kr/0.5PRF scaffold showed more antibacterial activity against gram-positive and gram-negative bacteria than PCL/Kr sample. Based on enzyme-linked immunosorbent assays, the PCL/Kr/0.5PRF sample revealed an independent release of VEGF and PDGF for 7 days. Cell viability studies demonstrated non-cytotoxic nature of PRF-containing dressings. Also, chorioallantoic membrane (CAM) assay was performed to evaluate the angiogenic potential of the wound dressings. The in vivo assessments also showed that PCL/Kr/0.5PRF accelerated the wound healing process in terms of collagen deposition and the formation of skin appendages which was comparable to the normal skin. Overall, the data presented in this study greatly suggest that the PCL/Kr/0.5PRF wound dressing could be a suitable candidate for wound healing and skin regeneration.
最近,纳米纤维结构在广泛的医学应用中显示出巨大的潜力。本研究旨在评估通过静电纺丝工艺制备的聚己内酯/角蛋白/富含血小板纤维蛋白(PCL/Kr/PRF)纤维支架的伤口愈合过程。利用多种技术全面表征了所得结构的化学、物理和生物学特性。结果表明,仅向 PCL/Kr(PCL/Kr/0.5PRF)样品中添加 0.5%w/v 的 PRF,纤维直径从 193.93 ± 64.80nm 减小到 65.98 ± 14.03nm,断裂应力与 PCL 样品相比增加了 18.27%(从 2.90 ± 0.80MPa 增加到 3.43 ± 0.90MPa)。PCL/Kr/0.5PRF 支架对革兰氏阳性菌和革兰氏阴性菌的抗菌活性均高于 PCL/Kr 样品。基于酶联免疫吸附试验,PCL/Kr/0.5PRF 样品在 7 天内可独立释放 VEGF 和 PDGF。细胞活力研究表明,含 PRF 的敷料具有非细胞毒性。此外,还进行了鸡胚尿囊膜(CAM)试验来评估伤口敷料的血管生成潜力。体内评估还表明,PCL/Kr/0.5PRF 可加速胶原沉积和皮肤附属物的形成,从而加速伤口愈合过程,与正常皮肤相当。总的来说,本研究的数据表明,PCL/Kr/0.5PRF 伤口敷料可能是伤口愈合和皮肤再生的合适候选材料。